Royal Bank of Canada
ANAC

Royal Bank of Canada’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Royal Bank of Canada’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-156,877
Closed -$8.38M – 6881
2016
Q1 		$8.38M Buy
156,877
+45,154
+40% +$3.33M 0.01% 1500
2015
Q4 		$12.6M Buy
111,723
+110,257
+7,521% +$12.1M 0.01% 1279
2015
Q3 		$173K Buy
1,466
+1,426
+3,565% +$186K ﹤0.01% 4441
2015
Q2 		$3K Sell
40
-100
-71% -$6.56K ﹤0.01% 6358
2015
Q1 		$8K Buy
140
+100
+250% +$4.25K ﹤0.01% 5652
2014
Q4 		$1K Buy
40
+32
+400% +$961 ﹤0.01% 6133
2014
Q3 		$0 Buy
+8
New +$163 ﹤0.01% 6462
2013
Q4 		– Sell
-486
Closed -$5K – 6638
2013
Q3 		$5K Buy
+486
New +$4.25K ﹤0.01% 5665

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Royal Bank of Canada's ANAC Position: Q2 2016 in Review

Royal Bank of Canada sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 156,877 shares — an estimated $8.38M sold.

Royal Bank of Canada first reported a position in ANAC in Q3 2013 and held it in 8 quarters. The position peaked at $12.6M in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Royal Bank of Canada reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Royal Bank of Canada sold 156,877 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $8.38M.
  • Royal Bank of Canada first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2013 and held it in 8 quarters.
  • Royal Bank of Canada's ANACOR PHARMACEUTICALS INC COM position peaked at $12.6M in Q4 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Royal Bank of Canada's 13F filing for Q2 2016, filed 15 Aug 2016.